Supreme Court Says Centre Can Respond To Plea Seeking Direction To Specify Side Effects Of Covishield Vaccine
1 week, 4 days ago

Supreme Court Says Centre Can Respond To Plea Seeking Direction To Specify Side Effects Of Covishield Vaccine

Live Law  

The Supreme Court on December 10 said the Union Government may file its response to an amendment application seeking that possible adverse effects of Oxford–AstraZeneca's Covishield should be specified in the vaccines including the treatment for those effects. Opposing this, Additional Solicitor General Aishwarya Bhati responded: "Mylords looked into the entire issue of COVID vaccination, which was disposed of by a reported judgment which deals with the aspect of AEFI. When Bhati remarked: "Even headache medicine has adverse effects," Gonsalves concluded: "Government said, this is 110% safe. Issue a writ of mandamus or any other appropriate writ, order or direction directing the above-appointed expert medical board to prepare a protocol for early detection of and timely treatment for the AEFI due to the Covid-19 vaccine such as the ones that led to the deaths of the daughters of Petitioners No.

Writ Issue Covid Effects Vaccine Court Order Petitioners Covishield  writ  application  seeking  adverse  effects  plea  gonsalves  vaccine  court  order  petitioners  covishield  issue  respond  supreme  direction  specify

History of this topic

Covishield | Plea in Supreme Court for probe panel for vaccine’s ‘risk factors’
7 months, 3 weeks ago

Covishield | Plea in Supreme Court for probe panel for vaccine’s ‘risk factors’

The Hindu  

The controversy over the safety aspects of the Covishield vaccine reached the Supreme Court on Wednesday, May 1, 2024, with a petition seeking the constitution of an expert medical panel to study the risk factors. Now after the document filed in UK court by the developer of Covishield, we are compelled to think on the risk and hazardous consequences of …

'Would Lead To A Social Disaster': Centre Appeals Against Kerala HC Decision To Reduce Covishield Dose Interval Of 84 Days
3 years, 3 months ago

'Would Lead To A Social Disaster': Centre Appeals Against Kerala HC Decision To Reduce Covishield Dose Interval Of 84 Days

Live Law  

The Centre has preferred an appeal before the Kerala High Court against a Single Bench order allowing the second dose of COVISHIELD to be administered prior to the prescribed interval of 84 days. The appeal has been filed through the Assistant Solicitor General of India P. Vijayakumar.By the aforesaid judgment, the Single bench had directed the appellants to make necessary …

No Fundamental Rights Of Petitioner Infringed: Govt Responds To Plea Challenging 84 Days Dose Interval For Covishield Vaccines
3 years, 3 months ago

No Fundamental Rights Of Petitioner Infringed: Govt Responds To Plea Challenging 84 Days Dose Interval For Covishield Vaccines

Live Law  

The Secretary to the Government submitted its counter-affidavit before the Kerala High Court on Thursday responding to the petition that challenged the prescribed 84 days gap between administering two doses of the Covishield vaccine. Accordingly, it was argued that the dose interval between the two doses of the Covishield vaccine under the COVID-19 vaccination drive had undergone a series of …

Madras High Court Issues Notice To SII, DCGI, ICMR On Plea By Volunteer Alleging Side Effects After 'Covishield' Trial
3 years, 10 months ago

Madras High Court Issues Notice To SII, DCGI, ICMR On Plea By Volunteer Alleging Side Effects After 'Covishield' Trial

Live Law  

The Madras High Court on Friday issued notice on a plea filed by a participant of the clinal trial of Oxford/Astra Zeneca vaccine 'Covishield' produced by the Serum Institute of India who allegedly suffered serious side effects after receiving the first dose in the trial. The petitioner, one Asif Riaz, alleges that he suffered from a severe side effect and …

Madras HC issues notice to Centre on plea asking Covishield vaccine to be declared unsafe
3 years, 10 months ago

Madras HC issues notice to Centre on plea asking Covishield vaccine to be declared unsafe

India Today  

The Madras High Court on Friday issued notices to the Union health ministry and the Drugs Controller General of India over a plea seeking directions that would declare Covishield vaccine to be unsafe. The Madras High Court was hearing a petition filed by one Asif Riaz who had participated in the clinical trials of Covishield as a volunteer. He said …

Discover Related